tosylphenylalanyl-chloromethyl-ketone and Ischemia

tosylphenylalanyl-chloromethyl-ketone has been researched along with Ischemia* in 1 studies

Other Studies

1 other study(ies) available for tosylphenylalanyl-chloromethyl-ketone and Ischemia

ArticleYear
Cell-specific caspase expression by different neuronal phenotypes in transient retinal ischemia.
    Journal of neurochemistry, 2001, Volume: 77, Issue:2

    Emerging evidence supports an important role for caspases in neuronal death following ischemia-reperfusion injury. This study assessed whether cell specific caspases participate in neuronal degeneration and whether caspase inhibition provides neuroprotection following transient retinal ischemia. We utilized a model of transient global retinal ischemia. The spatial and temporal pattern of the active forms of caspase 1, 2 and 3 expression was determined in retinal neurons following ischemic injury. Double-labeling with cell-specific markers identified which cells were expressing different caspases. In separate experiments, animals received various caspase inhibitors before the induction of ischemia. Sixty minutes of ischemia resulted in a delayed, selective neuronal death of the inner retinal layers at 7 days. Expression of caspase 1 was not detected at any time point. Maximal expression of caspase 2 was found at 24 h primarily in the inner nuclear and ganglion cell layers of the retina and localized to ganglion and amacrine neurons. Caspase 3 also peaked at 24 h in both the inner nuclear and outer nuclear layers and was predominantly expressed in photoreceptor cells and to a lesser extent in amacrine neurons. The pan caspase inhibitor, Boc-aspartyl fmk, or an antisense oligonucleotide inhibitor of caspase 2 led to significant histopathologic and functional improvement (electroretinogram) at 7 days. No protection was found with the caspase 1 selective inhibitor, Y-vad fmk. These observations suggest that ischemia-reperfusion injury activates different caspases depending on the neuronal phenotype in the retina and caspase inhibition leads to both histologic preservation and functional improvement. Caspases 2 and 3 may act in parallel in amacrine neurons following ischemia-reperfusion. These results in the retina may shed light on differential caspase specificity in global cerebral ischemia.

    Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Caspases; Cysteine Proteinase Inhibitors; Drug Administration Schedule; Electroretinography; Enzyme Induction; Eye Proteins; Interneurons; Ischemia; Male; Neurons; Ocular Hypertension; Oligodeoxyribonucleotides, Antisense; Phenotype; Premedication; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Retinal Diseases; Retinal Ganglion Cells; Tosylphenylalanyl Chloromethyl Ketone

2001